Considering that NOTCH3C455R provides a proliferative advantage to HSPCs in vivo it is possible that somatically acquired CADASIL-related NOTCH3 mutations in HSPCs could facilitate CH development. The gene discussed is NOTCH3; the disease is cyclic hematopoiesis.